Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Vikas Swarup says India shouldered responsibility as world's pharmacy during COVID-19

Ruchika Sharma15 Dec 2020 10:00 AM IST

New York: India emerged as a net provider of health security and successfully shouldered its responsibility as the pharmacy of the world, said Vikas...

Diabetes Management: Biocon, Mylan drug Kixelle gets positive opinion from European Medicines Agency

Ruchika Sharma14 Dec 2020 4:08 PM IST

New Delhi: Biotechnology firm Biocon on Monday said its subsidiary Biocon Biologics and Mylan have received a positive opinion from the European...

AstraZeneca to acquire Alexion in USD 39 billion deal to expand immunology

Ruchika Sharma14 Dec 2020 1:15 PM IST

Frankfurt: Britain's AstraZeneca has agreed to buy U.S. drugmaker Alexion Pharmaceuticals for $39 billion in its largest ever deal, diversifying away...

AstraZeneca discontinues Phase 3 trial of prostate cancer drug Truqap

Oxford COVID-19 vaccine can be available in India by first half of 2021: AstraZeneca Country President

Ruchika Sharma14 Dec 2020 12:33 PM IST

Pfizer, Bharat Biotech and Serum Institute have currently applied with the DCGI for emergency authorization of their vaccines in the country.

AstraZeneca to begin COVID vaccine trials with Sputnik V

Ruchika Sharma13 Dec 2020 11:30 AM IST

New Delhi: AstraZeneca is to start clinical trials to test a combination of its experimental COVID-19 vaccine with Russia's Sputnik V shot to see if...

NPPA pulls up manufacturers of Enoxaparin Injection after observing shortage in Chhattisgarh

Ruchika Sharma13 Dec 2020 11:00 AM IST

Raipur: The apex drug price regulatory body, the National Pharmaceutical Pricing Authority (NPPA) recently pulled up the manufacturers of...

COVID-19: Indian pharma firms vaccine plans

Ruchika Sharma13 Dec 2020 10:30 AM IST

New Delhi: Several Indian pharmaceutical companies are working to develop or manufacture at least eight anti-Covid-19 formulations as the world's...

Germany BioNTech CEO looks for more vaccine production

Ruchika Sharma13 Dec 2020 9:30 AM IST

New York: The chief executive of Germany's BioNTech SE said the biggest challenge facing it and partner Pfizer Inc now that their Covid-19 vaccine is...

Cipla Settles Patent Litigation over REVLIMID Capsules with Celgene, Bristol Myers in US

Ruchika Sharma12 Dec 2020 4:36 PM IST

As part of the settlement, the Parties will file Consent Judgments with the United States District Court for the District of New Jersey that enjoin...

OptraLABS gets ICMR approval for COVID-19 recovery test kits Optra-Shield

Ruchika Sharma12 Dec 2020 1:30 PM IST

"We are making Optra-Shield available at Rs 350 in India," said Abhi Gholap

Covid-19 development documents unlawfully accessed in cyberattack: Pfizer, BioNTech

Ruchika Sharma12 Dec 2020 11:48 AM IST

London: U.S. drugmaker Pfizer and its German partner BioNTech said on Wednesday that documents related to development of their COVID-19 vaccine had...

Alembic Pharma Secures USFDA Tentative Approval for Bosulif Generic Bosutinib 400 mg

Alembic Pharma gets USFDA nod for Asenapine Sublingual Tablets to treat bipolar disorder

Ruchika Sharma12 Dec 2020 11:39 AM IST

Asenapine is an atypical antipsychotic indicated for bipolar I disorder as adjunctive treatment to lithium or valproate in adults.

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok